Nearly 23% of pregnancies with fetal major CHDs exhibited adverse obstetric outcomes compared with 9% of those without them (adjusted OR 2.96, 95% CI 2.49-3.53), researchers led by Gitte Hedermann, MD ...
Relying solely on end-of-line testing isn't enough when security, traceability, and mission reliability are vital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback